EyePoint(EYPT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EYPT EyePoint

交易中 12-08 10:35:27 EST

18.61

+0.87

+4.90%

最高19.01	最低17.86	成交量45.74万
今开17.86	昨收17.74	日振幅6.51%
总市值15.41亿	流通市值11.15亿	总股本8,279万
成交额847.96万	换手率0.76%	流通股本5,991万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"EYPT","market":"US","secType":"STK","nameCN":"EyePoint","latestPrice":18.61,"timestamp":1765208126347,"preClose":17.74,"halted":0,"volume":457420,"delay":0,"floatShares":59905600,"shares":82787220,"eps":-2.998437,"marketStatus":"交易中","change":0.87,"latestTime":"12-08 10:35:27 EST","open":17.855,"high":19.01,"low":17.855,"amount":8479600.72896,"amplitude":0.065107,"askPrice":18.63,"askSize":210,"bidPrice":18.58,"bidSize":19,"shortable":3,"etf":0,"ttmEps":-2.998437,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765227600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":17.74,"preHourTrading":{"tag":"盘前","latestPrice":17.9,"preClose":17.74,"latestTime":"09:28 EST","volume":72200,"amount":1277279.1534000002,"timestamp":1765204080065},"postHourTrading":{"tag":"盘后","latestPrice":17.74,"preClose":17.74,"latestTime":"18:43 EST","volume":33449,"amount":593404.7005,"timestamp":1764978202967},"volumeRatio":2.354216,"impliedVol":0.558,"impliedVolPercentile":0.216},"requestUrl":"/m/hq/s/EYPT/wiki","defaultTab":"wiki","newsList":[{"id":"1150797872","title":"EyePoint获得独立数据安全监测委员会对Duravyu™在湿性年龄相关性黄斑变性关键三期临床试验的积极推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=1150797872","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150797872?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:02","pubTimestamp":1763553741,"startTime":"0","endTime":"0","summary":"EyePoint获得独立数据安全监测委员会对Duravyu™在湿性年龄相关性黄斑变性关键三期临床试验的积极推荐","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0109394709.USD","BK4588","BK4585","EYPT","LU0889565916.HKD","BK4007"],"gpt_icon":0},{"id":"1153527707","title":"EyePoint制药或与Cantor Fitzgerald联合提供及出售高达2亿美元的普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1153527707","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153527707?lang=zh_cn&edition=full","pubTime":"2025-11-07 07:23","pubTimestamp":1762471392,"startTime":"0","endTime":"0","summary":"EyePoint制药或与Cantor Fitzgerald联合提供及出售高达2亿美元的普通股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4007","EYPT","BK4585","LU0109394709.USD","LU0889565916.HKD","BK4588"],"gpt_icon":0},{"id":"1150470228","title":"EyePoint 2025财年Q3业绩会总结及问答精华：DuraVu临床进展与市场前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1150470228","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150470228?lang=zh_cn&edition=full","pubTime":"2025-11-06 06:11","pubTimestamp":1762380701,"startTime":"0","endTime":"0","summary":"我们相信DuraVu在市场上将有很好的定位。对照组将使用标签上的aflibercept，DuraVu每六个月给药一次。DuraVu的活性成分vorolanib通过阻断JAK1受体抑制IL-6信号传导，可能显著改善治疗效果。EyePoint Pharmaceuticals在2025年第三季度展示了其主要候选药物DuraVu的显著临床进展，特别是在湿性AMD和DME领域。尽管财务业绩有所下降，但公司强大的现金储备和持续的临床试验进展使其在2026年有望取得重要里程碑。管理层对DuraVu的市场潜力充满信心，预计其多机制作用将显著改善治疗效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYPT"],"gpt_icon":0},{"id":"1139866701","title":"EyePoint Pharmaceuticals Inc宣布启动Duravy治疗糖尿病性黄斑水肿的3期临床试验项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1139866701","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139866701?lang=zh_cn&edition=full","pubTime":"2025-10-15 04:02","pubTimestamp":1760472171,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals Inc宣布启动Duravy治疗糖尿病性黄斑水肿的3期临床试验项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYPT","LU0889565916.HKD","BK4007","BK4585","BK4588","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2574818970","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大涨5.21%报13.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574818970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574818970?lang=zh_cn&edition=full","pubTime":"2025-10-08 23:14","pubTimestamp":1759936452,"startTime":"0","endTime":"0","summary":"北京时间2025年10月08日23时14分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.21%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Xenetic Biosciences, Inc.、Cingulate Inc C/Wts 10/12/2026 、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Xenetic Biosciences, Inc.、Acurx Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为2631.72%、1258.79%、830.71%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Xenetic Biosciences, Inc.、Transcode Therapeutics, Inc.，振幅分别为107.47%、86.01%、63.90%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008231412a6b0e345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008231412a6b0e345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","EYPT","LU0320765992.SGD","BK4585","BK4588","BK4007","LU0889565916.HKD"],"gpt_icon":0},{"id":"2565516478","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.09%报12.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565516478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565516478?lang=zh_cn&edition=full","pubTime":"2025-09-05 22:09","pubTimestamp":1757081382,"startTime":"0","endTime":"0","summary":"北京时间2025年09月05日22时09分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.09%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Fortress Biotech, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026涨幅较大，Cero Therapeutics Holdings, Inc.、Novabay Pharmaceuticals, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为338.85%、82.56%、44.48%，振幅较大的相关个股有Propanc Biopharma, Inc.、Humacyte Inc C/Wts 27/08/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为27.78%、26.94%、23.89%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905220942977a6c45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905220942977a6c45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","PT","LU0889565916.HKD","EYPT","BK4166","BK4588","LU0109394709.USD","BK4007","BK4585"],"gpt_icon":0},{"id":"2557593464","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 下午盘急速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557593464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557593464?lang=zh_cn&edition=full","pubTime":"2025-08-08 02:56","pubTimestamp":1754593003,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日02时56分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.01%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc C/Wts 10/12/2026 、C4 Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Bioxcel Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为1852.85%、220.90%、110.07%，振幅较大的相关个股有Palisade Bio, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Omniab Inc C/Wts ，振幅分别为105.51%、82.50%、59.72%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808025644a47b8662&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808025644a47b8662&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EYPT","BK4585","BK4588","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","BK4007"],"gpt_icon":0},{"id":"2557392967","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557392967","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557392967?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:37","pubTimestamp":1754401045,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日21时37分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.23%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为3.11%。其相关个股中，Y-Mabs Therapeutics, Inc.、Shattuck Labs, Inc.、Adaptimmune Therapeutics Plc涨幅较大，Shattuck Labs, Inc.、Adaptimmune Therapeutics Plc、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为105.59%、79.04%、65.16%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、凯信远达、Shattuck Labs, Inc.，振幅分别为15.53%、14.87%、14.41%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805213725a476b925&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805213725a476b925&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0889565916.HKD","BK4585","EYPT","LU0109394709.USD","LU0320765992.SGD","BK4007"],"gpt_icon":0},{"id":"2555002869","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大涨5.08%报10.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555002869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555002869?lang=zh_cn&edition=full","pubTime":"2025-07-30 22:34","pubTimestamp":1753886080,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日22时34分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.08%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Replimune Group, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Tnf Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.、Replimune Group, Inc.较为活跃，换手率分别为263.32%、129.58%、129.18%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Replimune Group, Inc.，振幅分别为53.86%、47.44%、40.93%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507302234409727fa41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507302234409727fa41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0889565916.HKD","BK4585","EYPT","LU0109394709.USD","LU0320765992.SGD","BK4007"],"gpt_icon":0},{"id":"2552872014","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552872014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552872014?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:30","pubTimestamp":1752762632,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时30分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.15%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Marker Therapeutics, Inc.、Immuron Limited较为活跃，换手率分别为851.89%、346.31%、187.56%，振幅较大的相关个股有Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为148.12%、81.11%、61.18%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071722303297a9e39d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071722303297a9e39d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","EYPT","BK4588","LU0889565916.HKD","LU0109394709.USD","BK4585","LU0320765992.SGD"],"gpt_icon":0},{"id":"2549525280","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549525280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549525280?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:31","pubTimestamp":1751985106,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日22时31分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.37%。截至发稿，该股报10.00美元/股，成交量10.715万股，换手率0.16%，振幅3.79%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Moleculin Biotech, Inc.、Rallybio Corporation、Humacyte, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃，换手率分别为879.71%、433.93%、263.78%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Moleculin Biotech, Inc.、Rallybio Corporation，振幅分别为70.96%、69.44%、59.87%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223147953af386&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223147953af386&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","EYPT","BK4007","LU0889565916.HKD","BK4585","LU0109394709.USD","BK4588"],"gpt_icon":0},{"id":"2548770813","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 快速上涨5.03%报10.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548770813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548770813?lang=zh_cn&edition=full","pubTime":"2025-07-02 22:13","pubTimestamp":1751465611,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日22时13分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.03%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Nutriband Inc C/Wts 涨幅较大，Windtree Therapeutics, Inc.、Lixte Biotechnology Holdings, Inc.、Aditxt, Inc.较为活跃，换手率分别为1773.34%、495.47%、128.47%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Lixte Biotechnology Holdings, Inc.，振幅分别为1145.92%、300.85%、96.61%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702221331a72ace63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702221331a72ace63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","EYPT","LU0320765992.SGD","BK4585","BK4588","BK4007","LU0889565916.HKD"],"gpt_icon":0},{"id":"2546747876","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.30%报9.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546747876","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546747876?lang=zh_cn&edition=full","pubTime":"2025-06-27 22:23","pubTimestamp":1751034195,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日22时23分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.30%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Inmune Bio Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、天境生物涨幅较大，Inmune Bio Inc.、Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.较为活跃，换手率分别为98.01%、49.27%、26.41%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Channel Therapeutics Corporation、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为74.75%、62.62%、33.25%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062722231697917e9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062722231697917e9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4007","BK4585","EYPT","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD"],"gpt_icon":0},{"id":"2546424002","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大涨5.01%报9.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546424002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546424002?lang=zh_cn&edition=full","pubTime":"2025-06-26 01:48","pubTimestamp":1750873718,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日01时48分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.01%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。其相关个股中，Plus Therapeutics, Inc.、Vor Biopharma Inc.、Aditxt, Inc.涨幅较大，Seastar Medical Holding Corporation、Plus Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为2315.65%、1308.84%、330.30%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Vor Biopharma Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为159.26%、92.77%、88.27%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626014839952b7714&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626014839952b7714&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EYPT","BK4588","LU0889565916.HKD","BK4585","BK4007","LU0109394709.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2545015446","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大跌5.17%报7.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545015446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545015446?lang=zh_cn&edition=full","pubTime":"2025-06-24 00:33","pubTimestamp":1750696399,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日00时33分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.17%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Cidara Therapeutics, Inc.涨幅较大，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Nucana Plc较为活跃，换手率分别为2757.89%、2083.25%、778.25%，振幅较大的相关个股有Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为273.41%、79.75%、71.02%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624003319a71954ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624003319a71954ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EYPT","BK4588","LU0889565916.HKD","BK4007","BK4585","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2544176664","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.04%报8.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544176664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544176664?lang=zh_cn&edition=full","pubTime":"2025-06-20 22:58","pubTimestamp":1750431539,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日22时58分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.04%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。消息层面，截至22时58分，《加皇资本市场首予EyePoint Pharmaceuticals买入评级，目标价28美元》资讯为影响Eyepoint Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062022585997881dce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062022585997881dce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EYPT","LU0109394709.USD","BK4585","BK4007","LU0889565916.HKD","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2544998122","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544998122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544998122?lang=zh_cn&edition=full","pubTime":"2025-06-17 21:34","pubTimestamp":1750167291,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日21时34分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.26%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Acurx Pharmaceuticals, Inc.、Processa Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.涨幅较大，Cero Therapeutics Holdings, Inc.、Salarius Pharmaceuticals, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为1944.10%、1498.85%、941.48%，振幅较大的相关个股有Acurx Pharmaceuticals, Inc.、Processa Pharmaceuticals, Inc.、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为61.87%、53.93%、44.08%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617213452a70e706a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617213452a70e706a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EYPT","LU0109394709.USD","LU0889565916.HKD","BK4007","LU0320765992.SGD","BK4585","BK4588"],"gpt_icon":0},{"id":"2542944534","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 急速下跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542944534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542944534?lang=zh_cn&edition=full","pubTime":"2025-06-12 02:31","pubTimestamp":1749666663,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日02时31分，Eyepoint Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.32%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Kazia Therapeutics Limited、Jupiter Neurosciences, Inc.、Synaptogenix, Inc.涨幅较大，Nucana Plc、Kazia Therapeutics Limited、Windtree Therapeutics, Inc.较为活跃，换手率分别为12051.56%、3460.86%、202.56%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Psyence Biomedical Ltd C/Wts 25/01/2029、Kazia Therapeutics Limited，振幅分别为88.67%、84.50%、79.16%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612023103a7040427&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612023103a7040427&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","EYPT","BK4588","LU0889565916.HKD","LU0109394709.USD","BK4585","LU0320765992.SGD"],"gpt_icon":0},{"id":"2518289200","title":"Eyepoint Pharmaceuticals, Inc.2024财年实现净利润-1.31亿美元，同比减少85.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518289200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518289200?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:00","pubTimestamp":1741536045,"startTime":"0","endTime":"0","summary":"3月10日，Eyepoint Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-1.31亿美元，同比减少85.03%；其中营业收入为43.27百万美元，同比减少5.98%，每股基本收益为-2.32美元。从资产负债表来看，Eyepoint Pharmaceuticals, Inc.总负债81.96百万美元，其中短期债务1.25百万美元，资产负债比为0.06，流动比率为0.08。机构评级：截至2025年3月10日，当前有12家机构对Eyepoint Pharmaceuticals, Inc.目标价做出预测，其中目标均价为33.17美元，其中最低目标价为18.00美元，最高目标价为68.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000101a26897f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000101a26897f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EYPT"],"gpt_icon":0},{"id":"2517215166","title":"Eyepoint Pharmaceuticals, Inc.盘中异动 股价大跌5.02%报6.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517215166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517215166?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:30","pubTimestamp":1741271457,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时30分，Eyepoint Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.02%。Eyepoint Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Plus Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Exicure, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为904.80%、95.93%、44.61%，振幅较大的相关个股有Mbx Biosciences, Inc.、Tiziana Life Sciences Ltd、Neuphoria Therapeutics Inc.，振幅分别为8.18%、8.09%、5.97%。Eyepoint Pharmaceuticals, Inc.公司简介：EyePoint Pharmaceuticals Inc 是一家制药公司。其大部分收入来自美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223057abeb7730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223057abeb7730&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4007","BK4585","EYPT","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.eyepointpharma.com","stockEarnings":[{"period":"1week","weight":0.1962},{"period":"1month","weight":0.6105},{"period":"3month","weight":0.2662},{"period":"6month","weight":0.9843},{"period":"1year","weight":1.174},{"period":"ytd","weight":1.3812}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"EyePoint Pharmaceuticals Inc.于2008年3月成为特拉华州公司。其前身，pSivida有限公司于2000年12月在西澳大利亚注册成立一家澳大利亚公司。 pSivida开发微小，缓释，药物输送的产品。该公司用于药物输送的产品，依其设计，几个月或几年中都可控制和稳定输送药物速率。pSivida公司专注于利用其核心技术平台，Durasert和BioSilicon治疗眼睛后部的慢性疾病。 pSivida目前有三个认可的产品和两个主要正在开发的候选产品，这些产品代表了连续几代的Durasert技术平台。 pSivida公司开发的四分之三用于治疗视网膜疾病的缓释装置，目前已获得美国或欧洲联盟（欧盟）的批准。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.062972},{"month":2,"riseRate":0.380952,"avgChangeRate":-0.009351},{"month":3,"riseRate":0.380952,"avgChangeRate":-0.000657},{"month":4,"riseRate":0.52381,"avgChangeRate":0.155574},{"month":5,"riseRate":0.380952,"avgChangeRate":0.00075},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.02035},{"month":7,"riseRate":0.619048,"avgChangeRate":0.044584},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.024706},{"month":9,"riseRate":0.380952,"avgChangeRate":0.007468},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.047614},{"month":11,"riseRate":0.47619,"avgChangeRate":-0.049639},{"month":12,"riseRate":0.380952,"avgChangeRate":0.115044}],"exchange":"NASDAQ","name":"EyePoint","nameEN":"EyePoint"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"EyePoint(EYPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供EyePoint(EYPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"EyePoint,EYPT,EyePoint股票,EyePoint股票老虎,EyePoint股票老虎国际,EyePoint行情,EyePoint股票行情,EyePoint股价,EyePoint股市,EyePoint股票价格,EyePoint股票交易,EyePoint股票购买,EyePoint股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"EyePoint(EYPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供EyePoint(EYPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}